1. A method for determining pool financing structure of a venture capital fund, comprising:
inputting investment guidelines that specify initial investment parameters of companies that the venture capital fund intends to invest in and cash flow through the pool financing structure;
evaluating projected returns for equity investors and general partners of the venture capital fund by modeling fund investments and cash flow through the pool financing structure over a range of economic conditions;
modeling the venture capital fund for rating agencies to determine levels of subordination, within the pool financing structure, necessary to achieve investment guide ratings; and
determining optimal pool financing structure of the venture capital fund and optimal investment parameters of the companies based upon the economic conditions and the investment guide ratings, to maximize returns for the equity investors and general partners.
2. The method of claim 1, wherein inputting comprises inputting investment guidelines that specify an initial structure of investments in each of the companies.
3. The method of claim 1, wherein the method is employed in connection with raising initial capital for the venture capital fund.
4. The method of claim 1, wherein the method is employed in connection with restructuring an existing venture capital fund.
5. A method for determining pool financing structure of a venture capital fund, comprising:
inputting investment guidelines that specify initial investment parameters of companies that the venture capital fund intends to invest in and cash flow through the pool financing structure;
inputting capital commitment information of investors in the venture capital fund;
evaluating projected returns for the investors by modeling fund investments and cash flow through the pool financing structure over a range of economic conditions;
modeling the venture capital fund for the capital commitment, capital call and issue rated securities to determine optimal pool financing structure of the venture capital fund and optimal investment parameters of the companies based upon the economic conditions and the issue rated securities, to maximize returns for the investors.
6. The method of claim 5, wherein inputting comprises inputting investment guidelines that specify an initial structure of investments in each of the companies.
7. The method of claim 5, wherein the method is employed in connection with raising initial capital for the venture capital fund.
8. The method of claim 5, wherein the method is employed in connection with restructuring an existing venture capital fund.
9. A software product comprising instructions, stored on computer-readable media, wherein the instructions, when executed by a computer, perform steps for determining parameters of a venture fund, comprising:
instructions for inputting investment guidelines that specify initial investment parameters of companies that the venture capital fund intends to invest in and cash flow through the pool financing structure;
instructions for evaluating projected returns for equity investors and general partners of the venture capital fund by modeling fund investments and cash flow through the pool financing structure over a range of economic conditions;
instructions for modeling the venture capital fund for rating agencies to determine levels of subordination, within the pool financing structure, necessary to achieve investment guide ratings; and
instructions for determining optimal pool financing structure of the venture capital fund and optimal investment parameters of the companies based upon the economic conditions and the investment guide ratings, to maximize returns for the equity investors and general partners.
10. The software product of claim 9, wherein the instructions for inputting comprise instructions for inputting investment guidelines that specify an initial structure of investments in each of the companies.
11. The software product of claim 9, wherein the software product is employed in connection with raising initial capital for the venture capital fund.
12. The software product of claim 9, wherein the software product is employed in connection with restructuring an existing venture capital fund.
13. A software product comprising instructions, stored on computer-readable media, wherein the instructions, when executed by a computer, perform steps for determining pool financing structure of a venture capital fund, comprising:
instructions for inputting investment guidelines that specify initial investment parameters of companies that the venture capital fund intends to invest in and cash flow through the pool financing structure;
instructions for inputting capital commitment information of investors in the venture capital fund;
instructions for evaluating projected returns for the investors by modeling fund investments and cash flow through the pool financing structure over a range of economic conditions;
instructions for modeling the venture capital fund for capital commitment, capital call and issue rated securities to determine optimal pool financing structure of the venture capital fund and optimal investment parameters of the companies based upon the economic conditions and the issue rated securities, to maximize returns for the investors.
14. The software product of claim 13, wherein the instructions for inputting comprises instructions for inputting investment guidelines that specify an initial structure of investments in each of the companies.
15. The software product of claim 13, wherein the software product is employed in connection with raising initial capital for the venture capital fund.
16. The software product of claim 13, wherein the software product is employed in connection with restructuring an existing venture capital fund.
17. A system for leveraging capital of a venture capital fund, comprising:
memory for storing investment guidelines, fund goals, investment scenarios, and investment rating data;
a simulator for generating a model of a pool financing structure based upon the investment guidelines, fund goals, investment scenarios and investment rating data; and
a processor for executing the simulator to evaluate the performance of the pool financing structure and to determine optimal pool financing structure of the venture capital fund and optimal investment parameters of the companies, to maximize returns for investors in the venture capital fund.
18. The system of claim 17, the memory storing information of capital commitment by the investors, and the simulator generating the model to include one or more issue rated securities issued against the capital commitment.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method of preventing or treating peritonitis in a patient, the method comprising administering to the patient a therapeutically effective amount of an oxidative reductive potential water solution, wherein the solution comprises free chlorine species at a level of from about 10 ppm to about 200 ppm, wherein the solution is stable for at least two months, wherein the solution comprises anode water and cathode water, and wherein the solution has a pH of from about 6.4 to about 7.8, wherein the free chlorine species is selected from the group consisting of hypochlorous acid, hypochlorite ions, sodium hypochlorite, chloride ions, dissolved chlorine gas, and mixtures thereof.
2. The method of claim 1, comprising contacting the peritoneal tissue in the patient with a therapeutically effective amount of the oxidative reductive potential water solution.
3. The method of claim 1, comprising delivering a therapeutically effective amount of the oxidative reductive potential water solution to the patient’s peritoneal space.
4. The method of claim 3, wherein the oxidative reductive potential water solution is delivered to the patient’s peritoneal space intra-operatively, laproscopically or transabdominally.
5. The method of claim 3, comprising:
(a) gaining access to the peritoneal space in the patient;
(b) delivering to the peritoneal space from about 0.1 to about 10 L of the oxidative reductive potential water solution;
(c) allowing the oxidative reductive potential water solution to remain in the peritoneal space for a period of time sufficient to provide a therapeutic effect;
(d) optionally removing the oxidative reductive potential water solution; and
(e) optionally repeating steps (b)-(d).
6. The method of claim 1, wherein the peritonitis results from surgery, appendicitis, acute cholecystitis, peptic ulcer, diverticulitis, bowel obstruction, pancreatitis, pelvic inflammatory disease, mesenteric thrombosis, tumor, penetrating trauma, or a combination thereof.
7. The method of claim 1, wherein the peritonitis is associated with an infection by one or more microorganisms selected from the group consisting of viruses, bacteria, and fungi.
8. The method of claim 7, wherein the infection is by one or more bacteria selected from the group consisting of Pseudomonas aeruginosa, Escherichia coli, Enterococcus hirae, Acinetobacter baumannii, Acinetobacter species, Bacteroides fragilis, Enterobacter aerogenes, Enterococcus faecalis, Vancomycin resistant-Enterococcus faecium (VRE, MDR), Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Micrococcus luteus, Proteus mirabilis, Serratia marcescens, Staphylococcus aureus, Methicilin resistant-Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus saprophyticus, Streptococcus pneumoniae, Streptococcus pyogenes, Salmonella choleraesuis, Shigella dysenteriae, C. perfingens, Neisseria gonorrhea, Chlamydia trachomatis, Mycobaterium bovis, Chlamydia trachomatis, and combinations thereof.
9. The method of claim 7, wherein the infection is by one or more fungi selected from the group consisting of Candida albicans, Candida parapsilasis, Candida tropicalis, Trichophyton mentagrophytes and Aspergillus fumigaus.
10. The method of claim 1, further comprising administering to the patient a therapeutically effective amount of one or more additional therapeutic agents selected from the group consisting of anti-infective agents and anti-inflammatory agents.
11. The method of claim 1, wherein the pH of the oxidative reductive potential water solution is from about 7.4 to about 7.6.
12. The method of claim 1, wherein the oxidative reductive potential water solution comprises cathode water in an amount of from about 10% to about 50% by volume of the solution, and anode water in an amount of from about 50% to about 90% by volume of the solution.
13. The method of claim 1, wherein the solution comprises free chlorine species at a level of from about 50 ppm to about 80 ppm.
14. The method of claim 1, wherein the free chlorine species comprises from about 15 ppm to about 35 ppm hypochlorous acid.
15. The method of claim 1, wherein the free chlorine species comprises from about 25 ppm to about 50 ppm sodium hypochlorite.
16. The method of claim 1, wherein the free chlorine species comprises from about 15 ppm to about 35 ppm hypochlorous acid and from about 25 ppm to about 50 ppm sodium hypochlorite.
17. A method of preventing peritoneal adhesions in a patient, the method comprising administering to the patient an oxidative reductive potential water solution in an amount effective to prevent peritoneal adhesions, wherein the solution comprises free chlorine species at a level of from about 10 ppm to about 200 ppm, wherein the solution is stable for at least two months, wherein the solution comprises anode water and cathode water, wherein the solution has a pH of from about 6.4 to about 7.8, and wherein the free chlorine species is selected from the group selected from the group consisting of hypochlorous acid, hypochlorite ions, sodium hypochlorite, chlorite ions, chloride ions, dissolved chlorine gas, and mixtures thereof.
18. A method of preventing peritoneal abscesses in a patient, the method comprising administering to the patient an oxidative reductive potential water solution in an amount effective to prevent peritoneal abscesses, wherein the solution comprises free chlorine species at a level of from about 10 ppm to about 200 ppm, wherein the solution is stable for at least two months, wherein the solution comprises anode water and cathode water, wherein the solution has a pH of from about 6.4 to about 7.8, and wherein the free chlorine species is selected from the group selected from the group consisting of hypochlorous acid, hypochlorite ions, sodium hypochlorite, chlorite ions, chloride ions, dissolved chlorine gas, and mixtures thereof.
19. A method of preventing systemic complications in a patient with peritonitis, the method comprising administering to the patient an oxidative reductive potential water solution in an amount effective to prevent peritoneal adhesions, wherein the solution comprises free chlorine species at a level of from about 10 ppm to about 200 ppm, wherein the solution is stable for at least two months, wherein the solution comprises anode water and cathode water, wherein the solution has a pH of from about 6.4 to about 7.8, and wherein the free chlorine species is selected from the group selected from the group consisting of hypochlorous acid, hypochlorite ions, sodium hypochlorite, chlorite ions, chloride ions, dissolved chlorine gas, and mixtures thereof.